Why Ozempic and other weight-loss drugs are changing the face of snacking
People are buying healthier snacks and household food bills are dropping as GLP-1 weight-loss drugs alter eating habits.
People call GLP-1s life-changing. CT says it can't afford them.
Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...
Becker's Hospital Review2d
A crossroads for GLP-1s
In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...
A cure for her daughter's epilepsy was getting close. Then Trump froze health spending.
Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.
Is Global Partners LP (GLP) The Best Pipeline and MLP Stock to Invest In According to Analysts?
Global Partners LP (NYSE:GLP) reported a revenue of $4.19 billion in Q4 of 2024, missing estimates by $1.62 billion. EPS was ...
Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...
Healio6d
Societies take stand against off-brand GLP-1s over safety concerns
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
Expert sheds light on medical breakthroughs in obesity treatment
Unlock the latest advancements in obesity treatment. Expert insights reveal groundbreaking medical breakthroughs and ...
Hims & Hers Health: Developing A Better Understanding
Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...